Welcome to our dedicated page for Maximus SEC filings (Ticker: MMS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Maximus, Inc. filings document the regulatory record of a public government-services contractor with common stock listed under MMS. Its 8-K reports cover quarterly and annual operating results, financial condition, earnings guidance, capital-return actions, stock repurchase authorizations and senior officer changes.
The company’s proxy materials describe board elections, auditor ratification, advisory executive-compensation votes, equity compensation disclosures and shareholder voting results. Together, the filings address Maximus’s governance structure, executive compensation, common-stock capital actions and formal disclosures related to its U.S. Federal Services, U.S. Services and Outside the U.S. operating segments.
Maximus, Inc. director Raymond B. Ruddy reported an automatic equity-related transaction involving the company’s common stock. On 12/01/2025, he acquired 693.707 shares of Maximus common stock at a price of $0. These were credited as dividend equivalent rights tied to previously awarded restricted stock units, meaning each right is economically equivalent to one share of Maximus common stock and vests proportionately with the underlying RSUs.
Following this transaction, Ruddy beneficially owned a total of 315,939.624 shares of Maximus common stock in direct form. The filing indicates this was a routine update of his holdings and does not involve any sale of shares.
Maximus, Inc. principal accounting officer Theresa D. Golinvaux reported a small increase in her ownership of Maximus common stock. On 12/01/2025, she acquired 14.335 shares of common stock at a price of $0 per share, reflecting dividend equivalent rights tied to previously granted restricted stock units. After this transaction, she beneficially owns 12,828.548 shares directly. Each dividend equivalent right is described as the economic equivalent of one share of Maximus common stock and vests proportionately with the related restricted stock units.
Maximus, Inc. disclosed that officer Ilene Baylinson acquired additional common stock-related rights through dividend equivalents on restricted stock units. On 12/01/2025, she received 27.639 dividend equivalent rights, each economically equivalent to one share of Maximus common stock, at a price of $0 as part of her existing equity awards. Following this transaction, she beneficially owned 21,576.774 shares of common stock in direct ownership, reflecting accumulated equity compensation rather than an open-market purchase.
Maximus, Inc. director Michael J. Warren reported small increases in his company stock holdings. On 11/28/2025, he acquired 14.403 shares of Maximus common stock at a price of $86.111 per share, marked as a purchase. On 12/01/2025, he received an additional 39.07 shares with a stated price of $0 per share.
After these transactions, Warren beneficially owned 15,524.345 shares of Maximus common stock directly. The filing explains that the first transaction reflects shares purchased through a dividend reinvestment program, while the second represents dividend equivalent rights credited on previously awarded restricted stock units, each equivalent in value to one share of Maximus common stock.
Maximus, Inc. director Anne K. Altman reported an automatic acquisition of common stock linked to previously granted restricted stock units. On 12/01/2025, she acquired 10.632 shares of Maximus common stock at a price of $0 as dividend equivalent rights, which accrue on existing restricted stock units and vest in step with those awards. Following this transaction, she beneficially owned a total of 32,066.067 shares in direct form. Each dividend equivalent right is described as economically equivalent to one share of Maximus common stock.
Maximus, Inc. (MMS) filed a Form 4 reporting equity transactions by its Chief Financial Officer, David Mutryn. On 11/24/2025, he received 10,259 restricted stock units (RSUs) of Maximus common stock at a price of $0, increasing his direct beneficial ownership to 35,647.958 shares.
The RSUs vest ratably over three years on 09/30/2026, 09/30/2027, and 09/30/2028, with the possibility of deferred vesting under the award terms. On the same day, he made a gift of 4,000 shares of common stock to a charitable donor advised fund, reducing his direct beneficial ownership to 31,647.958 shares.
Maximus, Inc. (MMS) reported an equity award to its Chief Legal Officer on a Form 4. On 11/24/2025, the officer received 7,409 shares of common stock in the form of restricted stock units (RSUs) at a stated price of $0, reflecting a compensation grant rather than an open‑market purchase. After this grant, the officer beneficially owned 22,608.192 shares directly.
The RSUs vest in three equal annual installments on 09/30/2026, 09/30/2027, and 09/30/2028, with the ability to elect deferred vesting for a longer period as permitted by the award terms. Each RSU represents a contingent right to receive one share of Maximus common stock, aligning the executive’s compensation with the company’s equity over a multi‑year period.
MAXIMUS, Inc. (MMS) reported an equity award to a company officer on a Form 4. General Manager – Health & Human, Ilene Baylinson, received a grant of 7,409 restricted stock units (RSUs) of MAXIMUS common stock on 11/24/2025 at a stated price of $0, reflecting the nature of the award rather than a market purchase.
The RSUs vest in three equal annual installments on 09/30/2026, 09/30/2027, and 09/30/2028, subject to possible deferred vesting at the individual’s election as permitted by the award terms. Each RSU represents a contingent right to receive one share of common stock. Following this grant, Baylinson beneficially owns 21,549.135 shares of MAXIMUS common stock in direct ownership.
MAXIMUS, Inc. (MMS) reported a Form 4 transaction for its Chief of Human Resources, Michelle Link. On 11/24/2025, she received a grant of 6,013 restricted stock units (RSUs) of MAXIMUS common stock at a price of $0, reflecting an equity award rather than a purchase.
Following this grant, she beneficially owned 19,521.065 shares of MAXIMUS common stock in direct ownership. The RSUs vest on a three-year ratable schedule, with vesting dates on 09/30/2026, 09/30/2027, and 09/30/2028, and may be deferred for a longer period if elected under the award terms. Each RSU represents a contingent right to receive one share of common stock.
MAXIMUS, Inc. (MMS) reported an equity award to a senior executive. Principal Accounting Officer Theresa D. Golinvaux received a grant of 2,565 restricted stock units (RSUs) of common stock on 11/24/2025 at a price of $0 per share. These RSUs are scheduled to vest in four equal annual installments on 09/30/2026, 09/30/2027, 09/30/2028, and 09/30/2029, with the possibility of deferred vesting at her election under the award terms. After this grant, she beneficially owns 12,814.213 shares of MAXIMUS common stock in total.